| 1 |
34097888 | 4-Thiazolidinone-based derivatives do not affect differentiation of mouse embryo fibroblasts (3T3-L1 cell line) into adipocytes. | 2021 Aug 25 |
1 |
| 2 |
28854981 | Rosiglitazone increases endothelial cell migration and vascular permeability through Akt phosphorylation. | 2017 Aug 30 |
2 |
| 3 |
25889730 | Opposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progression. | 2015 Apr 15 |
1 |
| 4 |
23646053 | Expression of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ in the lung tissue of obese mice and the effect of rosiglitazone on proinflammatory cytokine expressions in the lung tissue. | 2013 Apr |
1 |
| 5 |
19152448 | Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition. | 2009 Jan 28 |
1 |
| 6 |
18599600 | Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair. | 2008 Oct |
1 |
| 7 |
18728224 | Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production. | 2008 Nov |
1 |
| 8 |
16672634 | Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARgamma agonist's effects on edema and weight gain. | 2006 Jun |
4 |
| 9 |
11346398 | Response of experimental retinal neovascularization to thiazolidinediones. | 2001 May |
1 |